Mupirocina Isdin (Mupirocin)

Mupirocin inhibits bacterial isoleucyl‑tRNA synthetase, a key enzyme in protein synthesis. By blocking this step, the drug prevents bacteria from producing essential proteins, leading to a bacteriostatic effect at low concentrations and a bactericidal effect when higher concentrations are reached at the site of application.

The dosage and frequency of Mupirocina Isdin are determined by the prescribing clinician based on the infection type, severity and patient characteristics. The product is applied topically as a thin layer to the affected area, and the prescriber provides specific instructions.

Safety data for mupirocin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mupirocin offers a narrow‑spectrum activity primarily against Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA). Compared with broader‑spectrum agents like fusidic acid, mupirocin has a distinct mechanism of action and is often preferred for infections where resistance to other agents is a concern.

Store Mupirocina Isdin at temperatures below 25 °C in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability and potency.

Apply a thin layer of the ointment or cream to the cleaned, dry affected skin area, usually two to three times daily, or as directed by the prescriber. Avoid contact with eyes, mucous membranes and open wounds unless specifically instructed.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, and systemic effects like neutropenia from excessive absorption. Patients should seek immediate medical attention if they experience widespread rash, swelling, difficulty breathing or unexplained fever.

Individuals with a known hypersensitivity to mupirocin or any component of the formulation should avoid using the product. It is also contraindicated on extensive broken skin or in patients where a systemic antibiotic is required instead of a topical agent.